Company / PP&E (Net)
PROKIDNEY CORP. PP&E (Net) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$42.2M
FY2024
5-year range
$10.7M / $42.2M
FY2021-FY2024
Trend
+0.2%
vs FY2023
Sector context
#67 of 193
Health Care
What the data says
At $42M, PROKIDNEY CORP.'s pp&e (net) ranks #67 of 193 in the Health Care sector. Improved from $11M to $42M over the past 2 years.
Based on SEC 10-K filings.
$42M in FY2024 with a 3-year CAGR of +54.9%.
Improved from $11M to $42M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +54.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#67 of 193 in Health CareTop 35% of 193This company $42.2M Sector average $777.6M
▼
-94.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +54.9%, indicating consistent growth.
- In FY2024, pp&e (net) increased 0.2% year-over-year.
- Ranks #67 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $42.2M | +0.2% |
| FY2023 | $42.1M | +293.6% |
| FY2022 | $10.7M | -5.7% |
| FY2021 | $11.4M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026